Urinary tract cancer and hereditary nonpolyposis colorectal cancer: Risks and screening options

Journal of Urology

Volumn 160, Issue 2, 1998, Pages 466-470

  Sijmons, R H ^a   Kiemeney, L A L M ^a   Witjes, J A ^a   Vasen, H F A ^a  

^a NONE

Author keywords

Colorectal neoplasms, hereditary, nonpolyposis; Neoplastic syndromes, hereditary; Urinary tract

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER FAMILY; CANCER RISK; CANCER SCREENING; COLORECTAL CANCER; FAMILY HISTORY; FEMALE; HUMAN; KIDNEY CANCER; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA; URINARY TRACT CANCER;

EID: 0032322195     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)62926-4     Document Type: Article

References (37)

1. Hodgson, S. V. and Maher, E. R.: A Practical Guide to Human Cancer Genetics. Cambridge: Cambridge University Press, 1993.
2. Kiemeney, L. A. L. M. and Schoenberg, M.: Familial transitional cell carcinoma. J. Urol., 156: 867, 1996.
3. Lynch, H. T. and Smyrk, T.: Hereditary nonpolyposis colorectal cancer (Lynch syndrome). An updated review. Cancer, 78: 1149, 1996.
4. Mecklin, J. P. and Järvinen, H. J.: Tumor spectrum in cancer family syndrome (hereditary nonpolyposis colorectal cancer). Cancer, 68: 1109, 1991.
5. Watson, P. and Lynch, H. T.: Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer, 71: 677, 1993.
6. Järvinen, H. J., Mecklin, J. P. and Sistonen, P.: Screening reduces colorectal cancer rate in families with hereditary non-polyposis colorectal cancer. Gastroenterology, 108: 1405, 1995.
7. Burke, W., Petersen, G., Lynch, P., Botkin, J., Daly, M., Garber, J., Kahn, M. J., McTiernan, A., Offit, K., Thomson, E., Varricchio, C. and the Cancer Genetics Studies Consortium: Recommendations for follow-up care of individuals with an inherited predisposition to cancer: I. Hereditary nonpolyposis colon cancer. J.A.M.A., 277: 915, 1997.
8. Visser, O., Coebergh, J. W. W., van Leeuwen, F. E. and Schouten, L. J.: Incidence of cancer in The Netherlands, 1990. Second report of The Netherlands Cancer Registry (ISBN 90-72175-07-7). Utrecht: National Association of Comprehensive Cancer Centres, 1994.
9. Breslow, N. E. and Day, N. E.: The Design and Analysis of Cohort Studies. Lyon: IARC, 1987.
10. Zhang, Z.-F. and Steineck, G.: Epidemiology and etiology of bladder cancer. In: Principles and Practice of Genitourinary Oncology. Edited by D. Raghavan, H. I. Scher, S. A. Leibel and P. H. Lange. Philadelphia: Lippincott-Raven, chapt. 19, pp. 215-221, 1997.
11. Aarnio, M., Mecklin, J. P., Aaltonen, L. A., Nyström-Lahti, M. and Järvinen, H. J.: Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int. J. Cancer, 64: 430, 1995.
12. Vasen, H. F., Wijnen, J. T., Menko, F. H., Kleibeuker, J. H., Taal, B. G., Griffioen, G., Nagengast, F. M., Meijers-Heijboer, E. H., Bertario, L., Varesco, L., Bisgaard, M. L., Mohr, J., Fodde, R. and Khan, P. M.: Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology, 110: 1020, 1996.
13. Vasen, H. F. A., Mecklin, J. P., Meera Khan, P. and Lynch, H. T.: The International Collaborative Group on HNPCC. Anticancer. Res., 14: 1661, 1994.
14. Peltomäki, P. and de la Chapelle, A.: Mutations predisposing to hereditary nonpolyposis colorectal cancer. Adv. Cancer. Res., 71: 93, 1997.
15. Miyaki, M., Konishi, M., Tanaka, K., Kikuchi-Yanoshita, R., Muraoka, M., Yasuno, M., Igari, T., Koike, M., Chiba, M. and Mori, T.: Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer. Nat. Genet., 17: 271, 1997.
16. Rhyu, M. S.: Molecular mechanisms underlying hereditary non-polyposis colorectal carcinoma. J. Natl. Cancer. Inst., 88: 240, 1996.
17. Konishi, M., Kikuchi-Yanoshita, R., Tanaka, K., Muraoka, M., Onda, A., Okumura, Y., Kishi, N., Iwama, T., Mori, T., Koike, M., Ushio, K., Chiba, M., Nomizu, S., Konishi, F., Utsunomiya, J. and Miyaki, M.: Molecular nature of colon tumors in hereditary nonpolyposis colon cancer, familial polyposis, and sporadic colon cancer. Gastroenterology, 111: 307, 1996.
18. Lothe, R. A.: Microsatellite instability in human solid tumors. Mol. Med. Today, 3: 61, 1997.
19. Gonzalez-Zuleta, M., Ruppert, J. M., Tokino, K., Tsai, Y. C., Spruck, C. H., III, Miyao, N., Nichols, P. W., Hermann, G. G., Horn, T., Steven, K., Summerhayes, I. C., Sidransky, D. and Jones, P. A.: Microsatellite instability in bladder cancer. Cancer. Res., 53: 5620, 1993.
20. Mao, L., Lee, D. J., Tockman, M. S., Erozan, Y. S., Askin, F. and Sidransky, D.: Microsatellite alterations as clonal markers for the detection of human cancer. Proc. Natl. Acad. Sci., 91: 9871, 1994.
21. Orlow, I., Lianes, P., Lacombe, L., Dalbagni, G., Reuter, V. E. and Cordon-Cardo, C.: Chromosome 9 allelic losses and microsatellite alterations in human bladder tumors. Cancer Res., 54: 2848, 1994.
22. Uchida, T., Wada, C., Wang, C., Egawa, S., Ohtani, H. and Koshiba, K.: Genomic instability of microsatellite repeats and mutations of H-, K-, and N-ras, and p53 genes in renal cell carcinoma. Cancer Res., 54: 3682, 1994.
23. Uchida, T., Wang, C., Wada, C., Iwamura, M., Egawa, S. and Koshiba, K.: Microsatellite instability in transitional cell carcinoma of the urinary tract and its relationship to clinicopathological variables and smoking. Int. J. Cancer, 69: 142, 1996.
24. Cohen, P. R., Kohn, S. R., Davis, D. A. and Kurzrock, R.: Muir-Torre syndrome. Dermatol. Clin., 13: 79, 1995.
25. Aaltonen, L. A., Peltomäki, P., Mecklin, J. P., Järvinen, H., Jass, J. R., Green, J. S., Lynch, H. T., Watson, P., Tallqvist, G., Juhola, M., Sistonen, P., Hamilton, S. R., Kinzler, K. W., Vogelstein, B. and de la Chapelle, A.: Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients. Cancer. Res., 54: 1645, 1994.
26. Honchel, R., Halling, K. C., Schaid, D. J., Pittelkow, M. and Thibodeau, S. N.: Microsatellite instability in Muir-Torre syndrome. Cancer Res., 54: 1159, 1994.
27. Karsdorp, N., Elderson, A., Wittebol-Post, D., Hené, R. J., Vos, J., Feldberg, M. A., van Gils, A. P., Jansen-Schillhorn van Veen, J. M., Vroom, T. M., Hoppener, J. W. and Lips, C. J. M.: Von Hippel-Lindau disease: new strategies in early detection and treatment. Amer. J. Med., 97: 158, 1994.
28. Zbar, B., Tory, K., Merino, M., Schmidt, L., Glenn, G., Choyke, P., McClellan, M. W., Lerman, M. and Linehan, W. M.: Hereditary papillary renal cell carcinoma. J. Urol., 151: 561, 1994.
29. Choyke, P. L., Walther, M. M., Glenn, G. M., Wagner, J. R., Venzon, D. J., Lubensky, I. A., Zbar, B. and Linehan, W. M.: Imaging features of hereditary papillary renal cancers. J. Comput. Asst. Tomogr., 21: 737, 1997.
30. Weber, T.: Clinical surveillance recommendations adopted for HNPCC. Lancet, 348: 465, 1996.
31. Hilton, S. and Schwarz, L. H.: Radiologic imaging of genitourinary neoplasms. In: Principles and Practice of Genitourinary Oncology. Edited by D. Raghavan, H. I. Scher, S. A. Leibel and P. H. Lange. Philadelphia: Lippincott-Raven, chapt. 4, pp. 33-42, 1997.
32. Gourlay, W., Chan, V. and Gilks, C. B.: Screening for urothelial malignancies by cytologic analysis and flow cytometry in a community urologie practice: a prospective study. Mod. Path., 8: 394, 1995.
33. Kern, W. H.: The diagnostic accuracy of sputum and urine cytology. Acta Cytol., 32: 651, 1988.
34. Parry, W. L. and Hemstreet, G. P., III: Cancer detection by quantitative fluorescence image analysis. J. Urol., 139: 270, 1988.
35. Ho, K. J. and Kuo, S. H.: Urinary beta-glucuronidase activity as an initial screening test for urinary tract malignancy in high risk patients. Comparison with conventional urine cytologic evaluation. Cancer, 76: 473, 1995.
36. Mao, L., Schoenberg, M. P., Scicchitano, M., Erozan, Y. S., Merlo, A., Schwab, D. and Sidransky, D.: Molecular detection of primary bladder cancer by microsatellite analysis. Science, 271: 659, 1996.
37. Brooks, J. D. and Marshall, F. F.: Transitional cell carcinoma of the upper urinary tract. In: Principles and Practice of Genitourinary Oncology. Edited by D. Raghavan, H. I. Scher, S. A. Leibel and P. H. Lange. Philadelphia: Lippincott-Raven, chapt. 32, pp. 337-346, 1997.